277 related articles for article (PubMed ID: 22560838)
1. Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo.
Kniess T; Laube M; Bergmann R; Sehn F; Graf F; Steinbach J; Wuest F; Pietzsch J
Bioorg Med Chem; 2012 Jun; 20(11):3410-21. PubMed ID: 22560838
[TBL] [Abstract][Full Text] [Related]
2. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
3. Radiosynthesis and Biological Evaluation of [
Litchfield M; Wuest M; Glubrecht D; Wuest F
Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor.
Wuest F; Kniess T; Bergmann R; Pietzsch J
Bioorg Med Chem; 2008 Aug; 16(16):7662-70. PubMed ID: 18650097
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor.
Kniess T; Bergmann R; Kuchar M; Steinbach J; Wuest F
Bioorg Med Chem; 2009 Nov; 17(22):7732-42. PubMed ID: 19822433
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography.
Gester S; Wuest F; Pawelke B; Bergmann R; Pietzsch J
Amino Acids; 2005 Dec; 29(4):415-28. PubMed ID: 15997411
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression.
Kuge Y; Katada Y; Shimonaka S; Temma T; Kimura H; Kiyono Y; Yokota C; Minematsu K; Seki K; Tamaki N; Ohkura K; Saji H
Nucl Med Biol; 2006 Jan; 33(1):21-7. PubMed ID: 16459255
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2).
Kaur J; Tietz O; Bhardwaj A; Marshall A; Way J; Wuest M; Wuest F
ChemMedChem; 2015 Oct; 10(10):1635-40. PubMed ID: 26287271
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
14. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
[TBL] [Abstract][Full Text] [Related]
15. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.
de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F
Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
de Vries EF; Doorduin J; Dierckx RA; van Waarde A
Nucl Med Biol; 2008 Jan; 35(1):35-42. PubMed ID: 18158941
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors.
McCarthy TJ; Sheriff AU; Graneto MJ; Talley JJ; Welch MJ
J Nucl Med; 2002 Jan; 43(1):117-24. PubMed ID: 11801714
[TBL] [Abstract][Full Text] [Related]
18. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors.
Koehler L; Graf F; Bergmann R; Steinbach J; Pietzsch J; Wuest F
Eur J Med Chem; 2010 Feb; 45(2):727-37. PubMed ID: 19954867
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
